Browser does not support script.
Birmingham has been at the forefront of transplants since the pioneering work of Sir Peter Medawar. Our researchers are continuing his legacy.
Our research focuses on understanding the drivers of age-related inflammation, how this contributes to age-related disease and developing innovative ways to improve health in old age.
Developing the use of sensors and clocks in innovative, ground-breaking technologies to change the future landscapes of healthcare, transport, defence, civil engineering and more.
Academia partnering with business, investigating, developing and co-creating robust and innovative solutions to achieve responsible business success. Building the foundations for a more responsible and sustainable future.
We are working with partners across the globe to understand how to save lives at risk from poor air quality.
Birmingham academics work on major issues in international ethics and global justice and train the next generation of students to tackle these issues.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences we discover, apply and translate science, forging major advances in human and environmental health.
With over 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
From basic science to clinical trials, we cover every aspect of research into inflammation, the role it plays in human ageing and age-related inflammatory disease as well as the response to trauma. Our outstanding research has been recognised by the award of seven Centres of Excellence.
Research led by the University of Birmingham has found that vapourised e-liquid fluid has a similar effect on the lungs and body to those seen in regular cigarette smokers and patients with chronic lung disease.
Over 10 million people in the UK have arthritis. Discover what we’re doing to change the way we diagnose and treat it.
Women In Science
Osteoarthritis Research with Dr Simon Jones
Ageing research at Birmingham
Graduate stories: Lisa Hill
Posted 22 November 2018
A ground-breaking new centre has opened at the Queen Elizabeth Hospital in Birmingham that will develop innovative new treatments for patients affected by scar related injuries. The Scar Free Foundation Centre for Conflict Wound Research aims to make scar free healing within a generation.
Posted 26 September 2018
The Arthritis Therapy Acceleration Programme (A-TAP) is a £7 million concept funded by the Kennedy Trust for Rheumatology Research. It brings together the University of Birmingham, the University of Oxford and seven NHS partners.
Posted 12 September 2018
The University of Birmingham's annual Agewell event took place in Birmingham city centre on Monday 10 September, led by Professor Janet Lord, Director of the Institute of Inflammation and Ageing and the MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research.
View all news